Morgan Stanley Starts Clementia Pharmaceuticals Inc. (CMTA) at Overweight
Tweet Send to a Friend
Morgan Stanley initiates coverage on Clementia Pharmaceuticals Inc. (NASDAQ: CMTA) with a Overweight rating and a price ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE